Cargando…
Osteosarcoma cells/cell lines are not appropriate for studies on bone regeneration in vitro
Cite this article: Bone Joint Res 2023;12(5):311–312.
Autores principales: | Xu, Chunfeng, Liu, Yuelian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Editorial Society of Bone & Joint Surgery
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161142/ https://www.ncbi.nlm.nih.gov/pubmed/37144570 http://dx.doi.org/10.1302/2046-3758.125.BJR-2023-0088.R1 |
Ejemplares similares
-
Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy
por: Xu, Chunfeng, et al.
Publicado: (2021) -
Paradox: Curcumin, a Natural Antioxidant, Suppresses Osteosarcoma Cells via Excessive Reactive Oxygen Species
por: Xu, Chunfeng, et al.
Publicado: (2023) -
To B (Bone Morphogenic Protein-2) or Not to B (Bone Morphogenic Protein-2): Mesenchymal Stem Cells May Explain the Protein’s Role in Osteosarcomagenesis
por: Xu, Chunfeng, et al.
Publicado: (2021) -
Bone Microenvironment, Stem Cells, and Bone Tissue Regeneration
por: Lu, ZuFu, et al.
Publicado: (2017) -
Reliable in vitro studies require appropriate ovarian cancer cell lines
por: Jacob, Francis, et al.
Publicado: (2014)